American trypanosomiasis

Handbook of Clinical Neurology

Volumn 114, Issue , 2013, Pages 103-123

  Carod Artal, Francisco Javier ^a  

^a UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

American trypanosomiasis; Chagas disease; Encephalitis; Stroke; Trypanosoma cruzi

Indexed keywords

EID: 84879862926     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53490-3.00007-8     Document Type: Chapter

References (153)

1. Aguilar H.M., Abad-Franch F., Dias J.C., et al. Chagas disease in the Amazon region. Mem Inst Oswaldo Cruz 2007, 102:47-56.
2. Altcheh J., Moscatelli G., Moroni S., et al. Adverse events after the use of benznidazole in infants and children with Chagas disease. Pediatrics 2011, 127:e212-e218.
3. Apt W. Current and developing therapeutic agents in the treatment of Chagas disease. Drug Des Devel Ther 2010, 4:243-253.
4. Aras R., da Matta J.A.M., Mota G., et al. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003, 81:414-416.
5. Arteaga-Fernandez E., Baretto A.C.P., Ianni B.M., et al. Cardiac thrombosis and embolism in patients having died of chronic Chagas cardiopathy. Arq Bras Cardiol 1989, 52:189-192.
6. Aufderheide A.C., Salo W., Madden M., et al. A 9,000 year record of Chagas' disease. Proc Natl Acad Sci U S A 2004, 101:2034-2039.
7. Bacal F., Silva C.P., Pires P.V., et al. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant 2010, 24:E29-E34.
8. Bacigalupo A., Torres-Pérez F., Segovia V., et al. Sylvatic foci of the Chagas disease vector Triatoma infestans in Chile: description of a new focus and challenges for control programs. Mem Inst Oswaldo Cruz 2010, 105:633-641.
9. Barr S.C. Canine Chagas' disease (American Trypanosomiasis) in North America. Vet Clin North Am Small Anim Pract 2009, 39:1055-1064.
10. Bastos C.J., Aras R., Mota G., et al. Clinical outcomes of thirteen patients with acute Chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis 2010, 4:e711.
11. Beard C.B., Pye G., Steurer F.J., et al. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 2003, 9:103-105.
12. Bern C., Montgomery S.P. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009, 49:e52-e54.
13. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review. JAMA 2007, 298:2171-2181.
14. Bern C., Montgomery S.P., Katz L., et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008, 21:476-482.
15. Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas' disease. Acta Cardiol 2000, 55:33-38.
16. Brisse S., Dujardin J.C., Tibayrenc M. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol 2000, 111:95-105.
17. Britto C.C. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 2009, 104:122-135.
18. Brutus L., Castillo H., Bernal C., et al. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg 2010, 83:1044-1047.
19. Buckner F.S., Navabi N. Advances in Chagas disease drug development: 2009-2010. Curr Opin Infect Dis 2010, 23:609-616.
20. Campos S.V., Strabelli T.M., Amato Neto V., et al. Risk factors for Chagas disease reactivation after heart transplantation. J Heart Lung Transplant 2008, 27:597-602.
21. Carod-Artal F.J. Chagas cardiomyopathy and ischemic stroke. Expert Rev Cardiovasc Ther 2006, 4:119-130.
22. Carod-Artal F.J. Stroke: a neglected complication of American trypanosomiasis (Chagas' disease). Trans R Soc Trop Med Hyg 2007, 101:1075-1080.
23. Carod-Artal F.J. Trypanosomiasis. International Neurology, a Clinical Approach 2009, 290-292. John Wiley, Oxford. R. Lisak, D. Truong, W. Carroll, R. Bhidayasiri (Eds.).
24. Carod-Artal F.J., Gascón J. Chagas disease and stroke. Lancet Neurol 2010, 9:533-542.
25. Carod-Artal F.J., Melo M., Vargas A.P. Stroke of cardioembolic origin in Chagas disease. Rev Neurol 2001, 33:311-315.
26. Carod-Artal F.J., Vargas A.P., Melo M., et al. "Top-of-the-basilar" syndrome and Chagas' disease. Rev Neurol 2002, 35:337-341.
27. Carod-Artal F.J., Vargas A.P., Melo M., et al. American Trypanosomiasis (Chagas' disease): an unrecognized cause of stroke. J Neurol Neurosurg Psychiatry 2003, 74:516-518.
28. Carod-Artal F.J., Vargas A.P., Horan T.A., et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005, 36:965-970.
29. Carod-Artal F.J., Ribeiro L da S., Vargas A.P. Awareness of stroke risk in chagasic stroke patients. J Neurol Sci 2007, 263:35-39.
30. Carod-Artal F.J., Horan T.A., Vargas A.P., et al. Cardioembolic stroke and ischemic small bowel infarction in a Chagas' disease patient. Eur J Neurol 2007, 14:e8.
31. Carod-Artal F.J., Vargas A.P., Falcao T. Stroke in asymptomatic Trypanosoma cruzi-infected patients. Cerebrovasc Dis 2011, 31:24-28.
32. Castro C., Macêdo V., Rezende J.M., et al. Longitudinal radiologic study of the esophagus, in an endemic area of Chagas disease, in a period of 13 years. Rev Soc Bras Med Trop 1994, 27:227-233.
33. Castro J.A., Montalto de Mecca M., Bartel L.C. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol 2006, 25:471-479.
34. Cerisola J.A., Rabinovich A., Alvarez M., et al. Chagas' disease and blood transfusion. Bol Oficina Sanit Panam 1972, 73:203-221.
35. Chagas C. Nova tripanozomiase humana: estudos sob a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., s. sp. Agente etiológico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz 1909, 1:159-218.
36. Chagas C. Nova entidade morbida do homem: rezumo geral de estudos etiolojicos e clínicos. Mem Inst Oswaldo Cruz 1911, 3:219-275.
37. Choi H.J., Cornford M., Wang L., et al. Acute Chagas' disease presenting with a suprasellar mass and panhypopituitarism. Pituitary 2004, 7:111-114.
38. Cohen J.E., Tsai E.C., Ginsberg H.J., et al. Pseudotumoral chagasic meningoencephalitis as the first manifestation of acquired immunodeficiency syndrome. Surg Neurol 1998, 49:324-327.
39. Cohen V., Ceballos V., Rodríguez N., et al. Chagas' disease as a cause of cerebral mass in a patient with lymphoblastic leukemia in remission. Arch Argent Pediatr 2010, 108:134-137.
40. Concetti H., Retegui M., Perez G., et al. Chagas' disease of the cervix uteri in a patient with acquired immunodeficiency syndrome. Hum Pathol 2000, 31:120-122.
41. Cordova E., Boschi A., Ambrosini J., et al. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis 2008, 12:589-592.
42. Corti M., Yampolsky C. Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop 2006, 39:85-88.
43. Coura J.R., Dias J.C.P. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem Inst Oswaldo Cruz 2009, 104:31-40.
44. de Andrade A.L., Zicker F., de Oliveira R.M., et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996, 348:1407-1413.
45. Derex L., Nighoghossian N., Perinetti M., et al. Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus. Neurology 2001, 57:2122-2125.
46. Dantas R.O., Godoy R.A. The lower esophageal sphincter in patients with Chagas disease with peristalsis and aperistalsis. Arq Gastroenterol 1983, 20:13-16.
47. Dias J.C. The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review. Rev Soc Bras Med Trop 1989, 22:147-156.
48. Diaz Granados C.A., Saavedra Trujillo C.H., Mantilla M., et al. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 2009, 9:324-330.
49. Duffy T., Bisio M., Altcheh J., et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. Plos Negl Trop Dis 2009, 3:e419.
50. El Ghouzzi M.H., Boiret E., Wind F., et al. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2010, 50:575-583.
51. Fernandes O., Santos S., Cupollillo E., et al. A mini-exon multiplex polymerase chain reaction to distinguish the major groups of Trypanosoma cruzi and T. rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 2001, 95:1-3.
52. Ferreira M.S., Borges A.S. Some aspects of protozoan infections in immunocompromised patients: a review. Mem Inst Oswaldo Cruz 2002, 97:443-457.
53. Ferreira M.S., Nishioka S.A., Rocha A., et al. Acute fatal trypanosome cruzi meningoencephalitis in a hemophilic patient. Am J Trop Med Hyg 1991, 45:723-727.
54. Flores-Chávez M., Fernández B., Puente S., et al. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008, 46:e44-e47.
55. Flores-Chávez M., Faez Y., Olalla J.M., et al. Fatal congenital Chagas' disease in a non-endemic area. Cases J 2008, 1:302.
56. Garcia S., Ramos C.O., Senra J.F.V., et al. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrob Agents Chemother 2005, 49:1521-1528.
57. Garcia-Bournissen F., Altcheh J., Panchaud A., et al. Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis. Arch Dis Child 2010, 95:224-228.
58. Gascón J., Albajar P., Cañas E., et al. Diagnosis, management, and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol 2007, 60:285-293.
59. Gascón J., Bern C., Pinazo M.J. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010, 115:22-27.
60. Genovese O., Ballario C., Storino R., et al. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr 1994, 54:190-196.
61. Guhl F., Pinto N., Aguilera G. Sylvatic triatominae: a new challenge in vector control transmission. Mem Inst Oswaldo Cruz 2009, 104:71-75.
62. Hamilton P.B., Lewis M.D., Cruickshank C., et al. Identification and lineage genotyping of South American trypanosomes using fluorescent fragment length barcoding. Infect Genet Evol 2011, 11:44-51.
63. Ho K.K.L., Anderson K.M., Kannel W.B., et al. Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 1993, 88:107-115.
64. Hoff R., Teixeira R.S., Carvalho J.S., et al. Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas' disease. N Engl J Med 1978, 298:604-606.
65. Iliovich E., Lopez R., Kum M., et al. Spontaneous chagasic peritonitis in a patient with AIDS. Medicina (B Aires) 1998, 58:507-508.
66. Jackson Y., Gétaz L., Wolff H., et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin-American migrants in Geneva. Switzerland. PLoS Negl Trop Dis 2010, 4:e592.
67. Jackson Y., Alirol E., Getaz L., et al. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis 2010, 51:e69-e75.
68. Jannin J., Villa L. An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 2007, 102:95-97.
69. Köberle F. The causation and importance of nervous lesions in American trypanosomiasis. Bull World Health Organ 1970, 42:739-743.
70. Lages-Silva E., Ramirez L.E., Silva-Vergara M.L., et al. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis 2002, 34:118-123.
71. Lambert N., Mehta B., Walters R., et al. Chagasic encephalitis as the initial manifestation of AIDS. Ann Intern Med 2006, 144:941-943.
72. Lane J.E., Olivares-Villagomez D., Vnencak-Jones C.L., et al. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue. Am J Trop Med Hyg 1997, 56:588-595.
73. Laranja F.S., Dias E., Nobrega G., et al. Chagas' disease: a clinical, epidemiological and pathologic study. Circulation 1956, 14:1035-1059.
74. Leiguarda R., Roncoroni A., Taratuto A.L., et al. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology 1990, 40:850-851.
75. Leon-Sarmiento F.E., Mendoza E., Torres-Hillera M., et al. Trypanosoma cruzi-associated cerebrovascular disease: a case-control study in Eastern Colombia. J Neurol Sci 2004, 217:61-64.
76. Lescure F.X., Le Loup G., Freilij H., et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis 2010, 10:556-570.
77. Lewis M.D., Ma J., Yeo M., et al. Genotyping of Trypanosoma cruzi: systematic selection of assays allowing rapid and accurate discrimination of all known lineages. Am J Trop Med Hyg 2009, 81:1041-1049.
78. Lima-Costa M.F., Castro-Costa E., Uchóa E., et al. A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (The Bambuí Study). Neuroepidemiology 2009, 32:122-128.
79. Lopes E.R., Marquez J.O., da Costa Neto B., et al. Association of encephalic vascular accidents and Chagas disease. Rev Soc Bras Med Trop 1991, 24:101-104.
80. Luquetti A.O., Tavares S.B.N., Oliveira R.A., et al. Sorologia como critério de cura em pacientes tratados com benznidazol. Títulos obtidos em chagásicos não tratados por imunofluorescencia indireta. Rev Soc Bras Med Trop 2008, 41:242-243.
81. Lury K.M., Castillo M. Chagas' disease involving the brain and spinal cord: MRI findings. AJR Am J Roentgenol 2005, 185:550-552.
82. Mady C., Cardoso R.H., Barretto A.C., et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994, 90:3098-3102.
83. Marchiori P.E., Alexandre P.L., Britto N., et al. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy. J Heart Lung Transplant 2007, 26:1091-1096.
84. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., et al. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
85. Marin-Neto J.A., Rassi A., Morillo C.A., et al. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 2008, 156:37-43. BENEFIT Investigators.
86. Martinez de Tejada B., Jackson Y., Paccolat C., et al. Congenital Chagas disease in Geneva: diagnostic and clinical aspects. Rev Med Suisse 2009, 5(2091-2082):2094-2096. Groupe Chagas Congénital Genéve.
87. Medeiros M.B., Guerra J.A., Lacerda M.V. Meningoencephalitis in a patient with acute Chagas disease in the Brazilian Amazon. Rev Soc Bras Med Trop 2008, 4:520-521.
88. Mejía-Jaramillo A.M., Peña V.H., Triana-Chávez O. Trypanosoma cruzi: Biological characterization of lineages I and II supports the predominance of lineage I in Colombia. Exp Parasitol 2009, 121:83-91.
89. Milei J., Guerri-Guttenberg R.A., Grana D.R., et al. Prognostic impact of Chagas disease in the United States. Am Heart J 2009, 157:22-29.
90. Moncayo A., Silveira A.C. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009, 104:17-30.
91. Muñoz J., Gómez i Prat J., Gállego M., et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 2009, 111:51-55.
92. Muñoz J., Coll O., Juncosa T., et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin-American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis 2009, 48:1736-1740.
93. Muñoz M.J., Murcia L., Segovia M. The urgent need to develop new drugs and tools for the treatment of Chagas disease. Expert Rev Anti Infect Ther 2011, 9:5-7.
94. Nóbrega A.A., Garcia M.H., Tatto E., et al. Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil. Emerg Infect Dis 2009, 15:653-655.
95. Nunes M.C.P., Barbosa M.M., Ribeiro A.L.P., et al. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J Neurol Sci 2009, 278:96-101.
96. Okumura M., Aparecida dos Santos V., Camargo M.E., et al. Prenatal diagnosis of congenital Chagas' disease (American trypanosomiasis). Prenat Diagn 2004, 24:179-181.
97. Oliveira J.S.M., Araujo R.L.C., Navarro M.A., et al. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983, 2:147-151.
98. Oliveira R.B., Rezende Filho J., Dantas R.O., et al. The spectrum of esophageal motor disorders in Chagas disease. Am J Gastroenterol 1995, 90:1119-1124.
99. Oliveira I., Torrico F., Muñoz J., et al. Congenital transmission of Chagas disease: a clinical approach. Expert Rev Anti Infect Ther 2010, 8:945-956.
100. Oliveira-Filho J., Viana L.C., Vieira de Melo R.M., et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas disease cohort. Stroke 2005, 36:2015-2017.
101. Otani M.M., Vinelli E., Kirchhoff L.V., et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009, 49:1076-1082.
102. Pagano M.A., Segura M.J., Di Lorenzo G.A., et al. Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann Neurol 1999, 45:403-406.
103. Paixao L.C., Ribeiro A.L., Valacio R.A., et al. Chagas disease: independent risk factor for stroke. Stroke 2009, 40:3691-3694.
104. Panamerican Health Organization Estimación cuantitativa de la enfermedad de Chagas en las Americas. Organización Panamericana de la Salud 2006, Montevideo, Uruguay.
105. Pereira K.S., Schmidt F.L., Barbosa R.L., et al. Transmission of chagas disease (American trypanosomiasis) by food. Adv Food Nutr Res 2010, 59:63-85.
106. Picollo M., Vassena C., Orihuela S., et al. High resistance to pyrethroid insecticides associated with ineffective field treatments in Triatoma infestans (Hemiptera: Reduviidae) from Northern Argentina. J Med Entomol 2005, 42:637-642.
107. Pinazo M.J., Espinosa G., Gállego M., et al. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg 2010, 82:583-587.
108. Pinto A.Y., Valente S.A., Valente Vda C., et al. Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Pará, Amapá and Maranhão observed between 1988 and 2005. Rev Soc Bras Med Trop 2008, 41:602-614.
109. Piron M., Vergés M., Muñoz J., et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2008, 48:1862-1868.
110. Pitella J.E. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 1984, 42:105-115.
111. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001, 1:92-100.
112. Punukollu G., Gowda R.M., Khan I.A., et al. Clinical aspects of the Chagas' heart disease. Int J Cardiol 2007, 115:279-283.
113. Ramirez J.D., Guhl F., Umezawa E.S., et al. Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods. J Clin Microbiol 2009, 47:3945-3951.
114. Rassi A., Rassi A.G., Rassi S.G., et al. Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features. Arq Bras Cardiol 1995, 65:377-387.
115. Rassi A., Rassi A., Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007, 115:1101-1108.
116. Reyes P.A., Vallejo M. Trypanocidal drugs for late stage, symptomatic CD (Trypanosoma cruzi infection). Cochrane Database Syst Rev 2005, 4:CD004102.
117. Ribeiro I., Sevcsik A.M., Alves F., et al. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl Trop Dis 2009, 3:e484.
118. Risso M.G., Garbarino G.B., Mocetti E., et al. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J Infect Dis 2004, 189:2250-2259.
119. Rochitte C.E., Oliveira P.F., Andrade J.M., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005, 46:1553-1558.
120. Rosemberg S., Chaves C.J., Higuchi M.L., et al. Fatal meningoencephalitis caused by reactivation of Trypanosoma cruzi infection in a patient with AIDS. Neurology 1992, 42:640-642.
121. Rossi M.A., Tanowitz H.B., Malvestio L.M., et al. Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl Trop Dis 2010, 4:e674.
122. Santos D.M., Martins T.A., Caldas I.S., et al. Benznidazole alters the pattern of cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection. Acta Trop 2010, 113:134-138.
123. Sartori A.M., Sotto M.N., Braz L.M., et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg 1999, 93:631-632.
124. Sartori A.M., Ibrahim K.Y., Nunes Westphalen E.V., et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007, 101:31-50.
125. Sánchez Negrete O., Mora M.C., Basombrío M.A. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005, 115:668-672.
126. Schijman A.G. RT-PCR in the diagnosis of Chagas disease: an overview of the workshop sponsored by PAHO/WHO. Rev Patol Trop 2009, 38:1411-1412. CD Rom.
127. Schmunis G.A., Yadon Z.E. Chagas disease: a Latin-American health problem becoming a world health problem. Acta Trop 2010, 115:14-21.
128. Schofield C.J., Dias J.C. The Southern Cone Initiative against Chagas Disease. Adv Parasitol 1999, 42:1-27.
129. Schofield C.J., Galvao C. Classification, evolution, and species groups within the Triatominae. Acta Trop 2010, 110:88-100.
130. Sica R.E., Gonzalez Cappa S.M., Sanz O.P., et al. Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull Soc Pathol Exot 1995, 88:156-163.
131. Silva N., O'Bryan L., Medeiros E., et al. Trypanosoma cruzi meningoencephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:342-349.
132. Silva A.E., Silva A.C., Faleiros A.C., et al. Acute Chagas' disease in postrenal transplant and treatment with benzonidazole. Ann Diagn Pathol 2010, 14:199-203.
133. Sosa-Estani S., Segura E.L. Etiological treatment in patients infected by Trypanosoma cruzi: experience in Argentina. Curr Opin Infect Dis 2006, 19:583-587.
134. Sosa-Estani S., Segura E.L., Ruiz A.M., et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998, 59:526-529.
135. Tarleton R.L., Reithinger R., Urbina J.A., et al. The challenges of Chagas disease: grim outlook or glimmer of hope. PLoS Med 2007, 4:e332.
136. Torrico F., Alonso-Vega C., Suarez E., et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004, 70:201-209.
137. Trabuco C.C., Pereira de Jesus P.A., Bacellar A.S., et al. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 2005, 62:170-171.
138. Troncon L.E., Aprile L.R., Oliveira R.B., et al. Abnormally rapid gastric emptying of an isosmotic liquid meal in patients with megaduodenum. Dig Dis Sci 2000, 45:2145-2150.
139. Urbina J.A. New advances in the management of a long-neglected disease. Clin Infect Dis 2009, 49:1685-1687.
140. Valente S.A., da Costa Valente V., das Neves Pinto A.Y., et al. Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Trans R Soc Trop Med Hyg 2009, 103:291-297.
141. Villanova M.G., Meneghelli U.G., Dantas R.O. Gallbladder motor function in chagasic patients with megacolon and/or megaesophagus. Digestion 1987, 36:189-194.
142. Villar J.C., Marin-Neto J.A., Ebrahim S., et al. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 2002, 1. CD003463.
143. Viotti R., Vigliano C. Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine. Expert Rev Anti Infect Ther 2007, 5:717-726.
144. Viotti R.J., Vigliano C., Laucella S., et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 2004, 90:655-660.
145. Viotti R., Vigliano C., Lococo B., et al. Long-term cardiac outcome of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006, 144:724-734.
146. Viotti R., Vigliano C.A., Alvarez M.G., et al. The impact of socioeconomic conditions on chronic Chagas disease progression. Rev Esp Cardiol 2009, 62:1224-1232.
147. Viotti R., Vigliano C., Lococo B., et al. Side effects of benznidazole as treatment in chronic Chagas disease; fears and realities. Expert Rev Anti Infect Ther 2009, 7:157-163.
148. World Health Organization (WHO) Chagas disease 2005, Seventeenth Programme Report UNDP/TDR, Geneva.
149. World Health Organization (WHO) Global burden of disease estimates: 2004 update 2008, WHO, Geneva, Switzerland.
150. Yadon Z.E., Schmunis G.A. Congenital Chagas disease: estimating the potential risk in the United States. Am J Trop Med Hyg 2009, 81:927-933.
151. Yoo T.W., Mlikotic A., Cornford M.E., et al. Concurrent cerebral American trypanosomiasis and toxoplasmosis in a patient with AIDS. Clin Infect Dis 2004, 39:e30-e34.
152. Zaidenberg M. Congenital Chagas' disease in the province of Salta, Argentina, from 1980 to 1997. Rev Soc Bras Med Trop 1999, 32:689-695.
153. Zingales B., Andrade S.G., Briones M.R., et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 2009, 104:1051-1054.